Sobi seeks European approval of Xiapex for Peyronies disease

Swedish Orphan Biovitrum (Sobi) has filed for an extension of the label for Xiapex (collagenase clostridium histolyticum) with the European Medicines Agency to include the indication of Peyronie's disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news